14-day Premium Trial Subscription Try For FreeTry Free
$3.32
+0.200 (+6.41%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $3.01 $5.38 Friday, 3rd May 2024 NEXI stock ended at $3.32. This is 6.41% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.58% from a day low at $3.10 to a day high of $3.49.
90 days $3.01 $11.90
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
Jul 19, 2023 $0.290 $0.300 $0.290 $0.290 39 026
Jul 18, 2023 $0.310 $0.310 $0.285 $0.300 92 840
Jul 17, 2023 $0.280 $0.298 $0.270 $0.298 165 070
Jul 14, 2023 $0.276 $0.284 $0.271 $0.271 80 627
Jul 13, 2023 $0.290 $0.296 $0.264 $0.284 280 941
Jul 12, 2023 $0.283 $0.298 $0.270 $0.297 90 611
Jul 11, 2023 $0.290 $0.290 $0.262 $0.283 67 075
Jul 10, 2023 $0.275 $0.296 $0.271 $0.281 33 852
Jul 07, 2023 $0.290 $0.290 $0.261 $0.284 98 383
Jul 06, 2023 $0.296 $0.297 $0.261 $0.285 126 599
Jul 05, 2023 $0.290 $0.300 $0.280 $0.290 48 481
Jul 03, 2023 $0.290 $0.290 $0.280 $0.280 31 440
Jun 30, 2023 $0.278 $0.305 $0.278 $0.282 140 586
Jun 29, 2023 $0.285 $0.308 $0.270 $0.273 147 492
Jun 28, 2023 $0.280 $0.310 $0.275 $0.285 115 490
Jun 27, 2023 $0.308 $0.317 $0.261 $0.280 404 890
Jun 26, 2023 $0.305 $0.320 $0.291 $0.310 263 080
Jun 23, 2023 $0.324 $0.330 $0.280 $0.280 226 600
Jun 22, 2023 $0.295 $0.399 $0.280 $0.324 2 395 108
Jun 21, 2023 $0.370 $0.370 $0.261 $0.261 923 262
Jun 20, 2023 $0.340 $0.400 $0.320 $0.371 316 979
Jun 16, 2023 $0.340 $0.365 $0.330 $0.350 255 556
Jun 15, 2023 $0.315 $0.329 $0.291 $0.326 274 096
Jun 14, 2023 $0.316 $0.348 $0.310 $0.320 84 534
Jun 13, 2023 $0.336 $0.340 $0.310 $0.313 104 526
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT